Steatosis non-invasive tests accurately predict metabolic dysfunction-associated steatotic liver disease, while fibrosis non-invasive tests fall short: Validation in U.S. adult population

作者
Ayesha Sualeheen,Sze‐Yen Tan,Robin M. Daly,Ekavi N. Georgousopoulou,Gavin Abbott,Stuart Keith Roberts,Jacob George,Elena S. George
出处
期刊:Clinics and Research in Hepatology and Gastroenterology [Elsevier BV]
卷期号:49 (7): 102649-102649 被引量:5
标识
DOI:10.1016/j.clinre.2025.102649
摘要

INTRODUCTION: Metabolic dysfunction associated steatotic liver disease (MASLD) has replaced NAFLD as the diagnostic standard. This study aimed to validate non-invasive tests (NITs) for hepatic steatosis and fibrosis, originally used for NAFLD, in predicting MASLD and advanced fibrosis, respectively, compared to transient elastography (TE). METHODS: This cross-sectional study used the NHANES database (2017-2020). Adults aged ≥18 years with valid TE status and without other steatotic liver diseases were included. Hepatic steatosis NITs were compared against controlled attenuation parameter (CAP)- diagnosed MASLD and fibrosis NITS were compared against liver stiffness measurement (LSM)-diagnosed advanced fibrosis. The diagnostic accuracy was assessed using weighted ROC analysis. RESULTS: Among 5305 participants (49.1 % males), MASLD prevalence was 42.8 % (CAP-diagnosed) and advanced fibrosis was identified in 10.4 % (LSM-diagnosed) in those with MASLD. Steatosis NITs showed good diagnostic accuracy for predicting MASLD (AUROC 0.836 to 0.862), with fatty liver index having the maximum Youden index (0.55). Fibrosis NITs indicated poor to fair diagnostic accuracy for predicting advanced fibrosis (AUROC 0.564 to 0.691) but indicated high negative predicted value (89 %-94 %). In age categorized subgroup analysis, fibrosis NITs performed poorly in those aged ≤ 35 years and had low specificity to exclude fibrosis in those aged ≥65 years but performed comparably to the overall MASLD cohort in those aged 36-64 years. CONCLUSION: In this population-based cohort of U.S. adults, all steatosis NITs demonstrated good diagnostic accuracy for MASLD. However, the fibrosis NITs showed limited diagnostic ability and were influenced by age, suggesting they should be used cautiously in general population.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
堪冷之完成签到,获得积分10
刚刚
求文献完成签到 ,获得积分10
刚刚
搞怪谷蓝发布了新的文献求助50
刚刚
1秒前
1秒前
Gulu_完成签到 ,获得积分10
1秒前
小画发布了新的文献求助10
2秒前
杨汐菥发布了新的文献求助10
2秒前
科研通AI6.3的应助被王晨采纳,获得10
3秒前
3秒前
MichaelQiang的应助被健壮的涑采纳,获得30
4秒前
4秒前
4秒前
小蘑菇的应助被北辰小狼采纳,获得10
4秒前
4秒前
towerman完成签到,获得积分10
5秒前
qqq完成签到,获得积分10
5秒前
烟花的应助被Fly采纳,获得10
6秒前
七月的应助被ercha采纳,获得10
7秒前
酷酷酷发布了新的文献求助10
7秒前
archer发布了新的文献求助10
7秒前
小碗发布了新的文献求助10
8秒前
充电宝的应助被你说什么采纳,获得10
8秒前
9秒前
10秒前
10秒前
Firsterchao发布了新的文献求助30
10秒前
NexusExplorer的应助被zhangzhuopu采纳,获得10
10秒前
yanhong发布了新的文献求助10
10秒前
愤青发布了新的文献求助10
11秒前
活泼忆曼完成签到,获得积分10
11秒前
11秒前
拉唑完成签到,获得积分10
11秒前
辰辰发布了新的文献求助10
11秒前
Wang完成签到,获得积分10
12秒前
形成发布了新的文献求助10
13秒前
qiqidawang完成签到,获得积分10
13秒前
平淡的翠安完成签到 ,获得积分10
14秒前
14秒前
天天快乐的应助被Dear采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188088
求助须知:如何正确求助?哪些是违规求助? 9575942
关于积分的说明 21844291
捐赠科研通 7785857
什么是DOI,文献DOI怎么找? 3435158
关于科研通互助平台的介绍 2559529
邀请新用户注册赠送积分活动 2482065